Interleukin-4 and CpG oligonucleotide therapy suppresses the outgrowth of tumors by activating tumor-specific Th1-type immune responses
Hiroishi, KazumasaLanguage:
english
Journal:
Oncology Reports
DOI:
10.3892/or.2012.1723
Date:
March, 2012
File:
PDF, 420 KB
english, 2012